BioSpace News Archive

Press Releases

Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor

April 20, 2026
·
3 min read
Press Releases

Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026

April 20, 2026
·
1 min read
Press Releases

Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®

April 20, 2026
·
10 min read
Press Releases

Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET

April 20, 2026
·
1 min read
Press Releases

Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer

April 20, 2026
·
3 min read
Press Releases

Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates

April 20, 2026
·
39 min read
Press Releases

Ascendis Pharma Announces Commencement of Trading of its Ordinary Shares on Nasdaq

April 20, 2026
·
4 min read
Press Releases

Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer

April 20, 2026
·
7 min read
Press Releases

Adcendo ApS Provides Updates on Pipeline Progress and Recent Achievements for Its First- and Best-in-Class Antibody-Drug Conjugates

April 20, 2026
·
5 min read
Press Releases

Accord BioPharma’s IMULDOSA® (ustekinumab-srlf) Now Preferred Under Cigna Healthcare Commercial Plans

April 20, 2026
·
9 min read